The President Elect, Vice President, Secretary Treasurer, and Medical Oncologist will be elected by all active members. The four regional board member positions will be elected by active members residing in the corresponding region.
The three Early Career Executive Committee positions will be elected by active Early Career Network members.
The online election is being managed by Simply Voting Inc., an independent, third-party election provider. IGCS Members with voting rights will receive an email with a personalized link to the online ballot from the email address, vote@simplyvoting.com starting on May 4, 2026. Those with sensitive spam filters are advised to add vote@simplyvoting.com to their email contacts list to ensure delivery.
If you have questions about the election or require assistance with voting, please email igcs@igcs.org.
Meet the Candidates Board of Directors
Candidates for President Elect

Read more about Joseph S. Ng

Prof. Andreas Obermair Queensland Centre for Gynaecological Cancer Research The University of Queensland Australia
Read more about Andreas Obermair
- Innovate surgical education and mentorship: We need to remain open to innovation and pass down surgical knowledge to future generations in the context of true multidisciplinary care. My surgical teaching was recognised through the IGCS Excellence in Teaching Award (2021), and I will be on faculty for the Train-the-Trainer workshop in Montreal.
- Expand research training: I would like more IGCS members taking leadership in high-quality clinical trials, which requires structured teaching and mentorship and should involve our IJGC journal.
- IGCS Guidelines: Existing treatment/diagnostic guidelines are sometimes not applicable in a global context. Dedicated IGCS guidelines should take into account high-level evidence, resources available locally, and patient preference.
- Increase patient advocacy because “nothing happens without patients” anywhere.
- While Artificial Intelligence has been revolutionary in many ways, it presents significant scientific and technological challenges. IGCS should create resources to ensure it supplements, rather than replaces our clinical judgement.
Candidates for Vice President

Read more about Dilyara Kaidarova
- Expanding Capacity Building in LMICs: Drawing from my experience in the former Soviet Union — a vast region with diverse healthcare challenges — I aim to strengthen sustainable gynecologic oncology services in low- and middle-income countries through tailored educational programs and mentorship.
- Strengthening Global Partnerships: By utilizing my roles in the ASCO International Affairs Committee, the Lancet Commission, and UICC, I will advocate for IGCS’s mission within the broader global health agenda, fostering collaborations that introduce international standards of care to underserved regions.
- Fostering Regional Collaboration: I am committed to building stronger professional networks across Asia, Oceania, and Eastern Europe, ensuring that advances in surgical techniques and systemic therapies reach women in all parts of the world.

Read more about Angélica Nogueira Rodrigues
Candidates for Secretary Treasurer Elect

Read more about Hennie Botha

Read more about M Samy Ismail
Candidates for Board Member Representing Medical Oncology

Read more about Susana Banerjee

Read more about Susana Maria Campos
Candidates for Board Member Representing Africa & Middle East

Read more about Sarah Al-Rubaish

Read more about Azza Chabchoub
Candidates for Board Member Representing Asia, Oceania, Pacific

Read more about Brahmana Askandar Tjokroprawiro
Position: Asia, Oceania, and Pacific Board Representative
Specialty: Gynecologic Oncology
Personal Statement: I am a Gynecologic oncologist at Universitas Airlangga / Dr. Soetomo General Academic Hospital in Surabaya, Indonesia, and currently serve as President of the Indonesian Society of Gynecologic Oncology (INASGO). I am motivated to serve on the IGCS Board to help strengthen collaboration across Asia, Oceania, and the Pacific, particularly by fostering greater connection between high-resource and resource-limited settings. Working in one of the largest middle-income countries in the region, I have seen firsthand the challenges of ensuring equitable access to quality Gynecologic cancer care. Over the past several years, I have been actively involved in collaborative efforts that connect clinicians, educators, and researchers across countries. Through INASGO, we have worked closely with IGCS as a strategic alliance partner since 2023, including hosting a monthly international multidisciplinary tumour board involving colleagues from Indonesia, Singapore, Japan, the United States, and other regions. This initiative reflects a shared commitment to practical, sustainable collaboration that directly impacts patient care, particularly in settings where resources remain limited. In parallel, I have contributed to regional and international educational initiatives, scientific meetings, and academic collaborations aimed at strengthening local capacity while maintaining strong international engagement. These experiences have reinforced my belief that progress in Gynecologic oncology depends not only on knowledge exchange, but also on mutual understanding across different healthcare systems. If elected, I hope to contribute to IGCS by supporting initiatives that expand access to education and training, strengthen regional collaboration, and promote inclusive partnerships. I would be honoured to support IGCS in advancing meaningful connections across diverse healthcare settings and improving Gynecologic cancer care globally.
Read more about Kate Harris

Read more about Nirmala CL Kampan
Position: Asia, Oceania, and Pacific Board Representative
Specialty: Gynecologic Oncology
Personal Statement: As a candidate for the IGCS Asia, Oceania and the Pacific Regional Board Representative, I am committed to advancing our shared mission of improving outcomes for women with gynecologic cancers through collaboration, innovation, and impactful education. My vision is to strengthen engagement across the Asia–Oceania–Pacific region by fostering inclusive, practice-oriented partnerships that translate into meaningful improvements in patient care. I am particularly passionate about creating greater opportunities for clinicians in Malaysia and neighboring countries to actively participate in and contribute to the global IGCS community, ensuring that regional perspectives help shape international standards and initiatives. A key priority is empowering the next generation of gynecologic oncology professionals. I aim to enhance IGCS educational and mentorship platforms to deliver accessible, high-impact training that equips early-career clinicians with practical skills and leadership capabilities. Through strong mentorship networks and regional collaboration, I hope to support young oncologists in becoming confident leaders and active contributors on the global stage. In my clinical and academic work, I have focused on advancing minimally invasive and robotic surgery, promoting evidence-based practice, and supporting capacity building in resource-variable settings. I am committed to strengthening cross-border collaboration in education and research to ensure that knowledge is translated into real-world improvements in care delivery. If elected, I will work to expand IGCS’s presence and impact across Malaysia and the wider region, amplify underrepresented voices, and promote equitable access to high-quality gynecologic cancer care. My goal is to help build a connected, empowered, and forward-looking community that delivers lasting improvements in women’s cancer outcomes worldwide.
Read more about Xiaohua Wu
- Standardization of Training & Credentialing While Western nations benefit from established certification systems that ensure high-quality patient care and clear career pathways, Asia requires similar standardization. I plan to leverage the IGCS’s global expertise to implement formal training and credentialing frameworks for gynecologic oncologists across Asia, with a specific emphasis on establishing these standards in China.
- Global Clinical Trial Integration Clinical trials are essential for validating new therapies. China offers immense potential through its vast patient population and growing pharmaceutical innovation. Utilizing my background as a Principal Investigator (PI) for landmark studies, I aim to elevate the role of China and Asian countries from participants to leaders in global multicenter research, ensuring our data contributes significantly to therapeutic advances.
Candidates for Board Member Representing Europe

Read more about Olga Matylevich
- Expanding the Tumor Board model into a formal mentorship network connecting emerging leaders from underrepresented European regions
- Advocating for educational content that reflects diverse clinical realities — from advanced robotics to low-resource innovations
- Ensuring that IGCS remains a responsive partner for every specialist on the continent, regardless of their country's economic history
- Exploring practical ways to reduce barriers to IGCS membership and conference participation for colleagues from lower-resource settings

Read more about Jo Morrison
Candidates for Board Member Representing Latin America

Read more about Jorge Hoegl

Read more about Luiz Felipe Lessa Ortiz
Meet the Candidates Early Career Network Executive Committee
Candidates for Early Career Network President

Read more about Vanessa Alvarenga Bezerra

Read more about Eric Rios-Doria
Candidates for Early Career Network President-Elect

Read more about Sara Maria Moufarrij

Read more about Sneja Raj
Candidates for Early Career Network Secretary Treasurer

Read more about Joanna Kacperczyk-Bartnik

Read more about Manisha Vernekar

login/create account
Donate